Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Conditions:   Uveal Melanoma;   Ocular Melanoma Interventions:   Drug: Pembrolizumab;   Drug: Olaparib Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Merck Sharp & Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials